Pfizer-BioNTech potential COVID-19 vaccine shows promise in additional data

Credit: REUTERS/ARND WIEGMANN

German biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.

Adds details, share movement

July 20 (Reuters) - German biotech firm BioNTech BNTX.O and U.S. drugmaker Pfizer PFE.N on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.

BioNtech's U.S. shares gained 12%, while Pfizer's stock rose 3.6% in early trading.

The companies said the data also demonstrated an induction of high level of T-cell responses against the novel coronavirus.

More than 150 possible vaccines are being developed and tested around the world to try to stop the pandemic. There are 23 candidates in human clinical trials, including from Moderna MRNA.O and AstraZeneca Plc AZN.L.

Experts have cautioned a safe and effective vaccine will take 12-18 months to develop.

The results were disclosed from a trial in Germany testing 60 healthy volunteers, and come after the companies earlier this month reported data from a corresponding early-stage trial in the United States.

The trial showed that volunteers given two doses of the vaccine produced virus-neutralizing antibodies, similar to the U.S. trial.

The data is available on an online preprint server at medrxiv and is undergoing scientific peer-review for potential publication, the companies said.

(Reporting by Manas Mishra and Ankur Banerjeee in Bengaluru; Editing by Sriraj Kalluvila)

((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BNTX PFE MRNA AZN

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More